Research Working Group      Policy Development Working Group      International Affairs Working Group

Linking Researchers and Industry

  • The Avicenna Alliance is dedicated to ensuring the full innovation cycle of predictive medicine is represented.
  • The Virtual Physiological Human (VPH) Initiative, carries a non-diminishable 50% board representation on the Avicenna Alliance with Industry representatives from Medical Devices, Pharmaceuticals and Software also maintaining a 50% board membership.
  • The VPH Institute is a massive network of Research Organisations and Universities engaged in predictive or in silico medicine.
  • The VPH institute has its origins in a European Commission endorsed research area on computer modeling and simulation and has been active for over 10 years.
  • This partnership of industry and researchers allows the Avicenna Alliance to address challenges to the predictive or in silico market from pre-clinical research all the way to post-market. 

Avicenna Alliance news

The Commission adopted a Communication on a new European Research Area for Research and Innovation

On 30 September the European Commission adopted a Communication on a new European Research Area for...

find out more ›

CADFEM Medical ONLINE Conference 2020

Under the motto "in vivo, in vitro, in silico - the central role of in silico medicine - what it can do and what we need for it", this year's specialist...

find out more ›

Avicenna provides feedback to the survey on the pharmaceutical strategy

On 15 September the Avicenna Alliance submitted Member's feedback to the survey on the pharmaceutical strategy! While...

find out more ›

Show all activites

Sign up for our monthly newsletter!


Sign up